Colorectal Neoplasms: all 5,738 studies
Page 11 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic CancerNot yet recruitingNCT06134765Phase 2
- Sulfasalazine in Patients With Metastatic Colorectal CancerRecruitingNCT06134388Phase 3
- Rural Indiana Screening for Colorectal CancerEnrolling by invitationNCT06133439Not applicable
- A Study of SGN-CEACAM5C in Adults With Advanced Solid TumorsRecruitingNCT06131840Phase 1
- A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal CancerRecruitingNCT06130280Phase 2
- Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.RecruitingNCT06128798Not applicable
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/2
- Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver MetastasesNot yet recruitingNCT06124729
- Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal CancerRecruitingNCT06118762Phase 4
- Acupressure on Postoperative Ileus in Patients With Colorectal Cancer SurgeryNot yet recruitingNCT06118060Not applicable
- Crisaborole Ointment for Skin Toxicity Induced by CetuximabRecruitingNCT06118047Phase 2
- Reducing Metabolic Dysregulation in DyadsRecruitingNCT06117241Not applicable
- Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal CancerNot yet recruitingNCT06115733Not applicable
- Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal CancerRecruitingNCT06114420
- GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal CancerRecruitingNCT06111105
- Medical Tai Chi Exercise Healing in Treating mCRC PatientsRecruitingNCT06104267Not applicable
- Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal CancerRecruitingNCT06102902Phase 1
- Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)RecruitingNCT06101277Not applicable
- A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing MethodRecruitingNCT06100016
- Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation TherapyNot yet recruitingNCT06099951Phase 2
- Fruquintinib in the Cross-line Treatment of Refractory mCRCRecruitingNCT06099314
- Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal PatientsRecruitingNCT06098560
- Discovering New Targets for Colorectal and Endometrial Cancer Risk ReductionRecruitingNCT06096688
- The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal CancerNot yet recruitingNCT06092242Phase 2
- Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine MonotherapyRecruitingNCT06090994Phase 4
- A Study of JMT101 in Patients With Metastatic Colorectal CancerNot yet recruitingNCT06089330Phase 2
- Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer ScreeningEnrolling by invitationNCT06085560Not applicable
- Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal CancerNot yet recruitingNCT06079242
- Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid TumorsRecruitingNCT06077591Not applicable
- DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid BiopsiesRecruitingNCT06076811
- LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer CachexiaRecruitingNCT06073431
- The Role of Lipid Transporter MFSD2A in the Resolution of Colorectal Cancer-associated InflammationRecruitingNCT06071598
- Robotic Right Hemicolectomy Versus Laparoscopic Right HemicolectomyNot yet recruitingNCT06067620Not applicable
- Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard TherapyRecruitingNCT06065371Phase 1
- Confronting Cancer as a CommunityRecruitingNCT06063928Not applicable
- Endoscopic Ultrasound- Guided Hartmann Reversal ProcedureNot yet recruitingNCT06061432Not applicable
- Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.RecruitingNCT06060704Phase 2
- A Prospective, Multi-center, Observational Study for Signal-C Test EvaluationRecruitingNCT06059963
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionRecruitingNCT06051695Phase 1/2
- Factors Affecting the Results of Treatment of Patients With Colorectal CancerRecruitingNCT06050447
- Nitazoxanide in Patients With Metastatic Colorectal CancerRecruitingNCT06049901Phase 3
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
- Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal CancerNot yet recruitingNCT06047015Phase 1/2
- Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsRecruitingNCT06040541Phase 1
- A Study of Mental Health Care in People With CancerRecruitingNCT06037954Not applicable
- Endoscopic Submucosal Dissection RegistryRecruitingNCT06033976
- MRD Application in Colorectal Cancer PatientsRecruitingNCT06028516
- KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsRecruitingNCT06026410Phase 1
- Safety and Efficacy of Polyvinyl Alcohol Sodium Acrylate Embolization Microspheres for CRLMNot yet recruitingNCT06021015Not applicable
- L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer PatientsRecruitingNCT06019312Not applicable
- Efficacy of Modified Fruquintinib in Colorectal Cancer Liver Metastases: A Phase II StudyRecruitingNCT06018714Phase 2
- Chemerin in Colorectal Cancer and Its Relationship With Diet QualityRecruitingNCT06018077
- Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal CancerRecruitingNCT06014372Phase 2
- LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer PatientsRecruitingNCT06012734Phase 1
- Continuous Glucose Monitoring for Colorectal CancerRecruitingNCT06011473Not applicable
- A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.RecruitingNCT06010901Phase 1
- Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRCRecruitingNCT06010888Phase 2
- A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal TumorsRecruitingNCT06008054Phase 2
- The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer SurgeryRecruitingNCT06006026Not applicable
- A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsRecruitingNCT06004245Phase 1
- Intraperitoneal Irinotecan With Concomitant FOLFOX and BevacizumabRecruitingNCT06003998Phase 2
- Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCCRecruitingNCT06002789Phase 2
- FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal CancerRecruitingNCT05999396Phase 1
- Impact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal CancerRecruitingNCT05993923Not applicable
- Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevacizumab in Refractory Metastatic Colorectal CancerRecruitingNCT05991102Not applicable
- A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsRecruitingNCT05989724Phase 1
- Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)RecruitingNCT05988645Not applicable
- Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed TherapyRecruitingNCT05985954Phase 1
- KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary CarcinomaNot yet recruitingNCT05985707Phase 2
- KN 046 Plus Regorafenib in MSS Metastatic Colorectal CancerRecruitingNCT05985109Phase 2
- Personalized Health Self-Management Training for Colorectal Cancer SurvivorsRecruitingNCT05984589Not applicable
- Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRCRecruitingNCT05970705Phase 2
- XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRCRecruitingNCT05970302Phase 2
- Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)RecruitingNCT05967143
- Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal CancerRecruitingNCT05963490Phase 2
- Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line TherapyRecruitingNCT05962502Phase 2
- Robotic Top-down Intersphincteric ResectionRecruitingNCT05961969
- Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal CancerRecruitingNCT05959356Phase 2
- Nutritional Risk Factors and Colorectal SurgeryRecruitingNCT05957744
- Multidimensional Rehabilitation Intervention in Colorectal Cancer Survivors - a Pilot StudyNot yet recruitingNCT05957289Not applicable
- Multidimensional Rehabilitation Intervention in Colorectal Cancer SurvivorsNot yet recruitingNCT05956990Not applicable
- A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 StudyRecruitingNCT05954429Phase 2
- Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal CancerRecruitingNCT05954078Phase 3
- Role of MRI in the Evaluation of Hepatic Metastases of Colorectal CancerRecruitingNCT05950503
- Fusobacterium Nucleatum at Colorectal Cancer SitesRecruitingNCT05945082Not applicable
- HTL0039732 in Participants With Advanced Solid TumoursRecruitingNCT05944237Phase 1/2
- Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After ChemotherapyRecruitingNCT05938504Not applicable
- SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuationRecruitingNCT05935384
- Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal CancerRecruitingNCT05933980Phase 2
- Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal CancerNot yet recruitingNCT05928312Not applicable
- FOG-001 in Locally Advanced or Metastatic Solid TumorsRecruitingNCT05919264Phase 1/2
- Dissecting the Biology of Early-onset Colorectal CancerNot yet recruitingNCT05916443
- Trial Feasibility of Home Delivery of Colon Capsule Endoscopy Service With the Help of 5 G TechnologyRecruitingNCT05914597Not applicable
- Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal CancerNot yet recruitingNCT05913570Phase 2
- Safety and Feasibility of Laparoscopic Intracorporeal Anastomosis for Colorectal Surgery- A Multiple Center Real World StudyRecruitingNCT05911152
- Combining Intratumoral Flu Vaccine and Systemic Pembrolizumab in Patients With Early pMMR Colorectal CancerNot yet recruitingNCT05909423Phase 2
- A First-In-Human Trial of pTTL in Advanced Colorectal CancerRecruitingNCT05908643Phase 1/2
- Virtual Rehabilitation for Cancer SurvivorsRecruitingNCT05898789Not applicable
- Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line TreatmentRecruitingNCT05897749Phase 4
- Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver MetastasesNot yet recruitingNCT05894837Phase 2